Fatigue that never seems to go away. Sudden weight gain despite eating carefully. Hair fall, mood swings and irregular periods. For many women, these symptoms immediately raise concerns about a ...
People with polyendocrine metabolic ovarian syndrome (PMOS) should have their condition diagnosed sooner and be offered an annual review to monitor symptoms, treatment and long-term health risks, ...
Women with polyendocrine metabolic ovarian syndrome (PMOS) should have annual checks so doctors can spot the wide-ranging health issues that can come with this complex condition, says new advice for ...
India faces falling fertility rates and rising infertility alongside widespread hormonal issues in women PCOS is renamed PMOS to highlight its metabolic and endocrine impacts beyond reproductive ...
Study suggests exposure to ‘forever chemicals’ may be a main driver of disease, formerly called PCOS, authors say New research for the first time links prenatal exposure to Pfas “forever chemicals” ...
Polycystic ovary syndrome (PCOS) has been renamed polyendocrine metabolic ovarian syndrome (PMOS). Professor Helena Teede led this name change after 14 years of research and global collaboration. But ...
Polyendocrine metabolic ovarian syndrome is underdiagnosed and inconsistently managed, according to Nice Up to 4 million women with irregular periods should be investigated for polyendocrine metabolic ...
Millions of women with the common hormonal condition polyendocrine metabolic ovarian syndrome (PMOS) could receive yearly NHS check-ups and earlier diagnosis under new draft guidance from the health ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
Ozempic (semaglutide) is Food and Drug Administration (FDA)-approved for type 2 diabetes. It may be prescribed off-label to help manage weight and metabolic concerns in people with PMOS (formerly PCOS ...
Patients with polyendocrine metabolic ovarian syndrome (PMOS) should be offered an annual review to monitor symptoms, medication and general health, NICE has recommended in new draft guidance. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results